Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
The Punch on MSN3d
The role of antioxidants in sickle cell managementOne of the major contributors to complications in SCD is oxidative stress, a condition where the body’s antioxidant defense ...
Learn how CASGEVY, the first NHS-approved CRISPR gene therapy, treats sickle cell disease through a revolutionary genetic ...
The Punch on MSN3d
I took exams in hospital bed battling sickle cell crises – UNILAG first-class graduateSo, when I was reading about Cell Biology and Genetics, I saw what it had to do, and one of the most common genetic examples ...
ROCHESTER, N.Y. – Researchers at Golisano Children’s Hospital have received a multi-million-dollar grant to lead a ...
Explore the benefits of adopting universal molecular genetic testing for newborn screening of haemoglobinopathies to improve ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
The growing incidence of genetic disorders and chronic illnesses, including cancer and rare inherited conditions, is fueling the demand for advanced therapies, highlighting the need for strong ...
Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback